Phosphate binders in CKD: Chalking out the differences

Pediatric Nephrology

Volumn 25, Issue 3, 2010, Pages 385-394

  Rees, Lesley ^a   Shroff, Rukshana C ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Calcium; Calciumacetate; Calciumcarbonate; Children; Lanthanum; Phosphate; Phosphate binders; Sevelamer

Indexed keywords

ADCAL; CALCICHEW; CALCICHEW FORTE; CALCIUM ACETATE; CALCIUM CARBONATE; CALCIUM SALT; CHITOSAN; FIBROBLAST GROWTH FACTOR 23; HYDROXYAPATITE; LANTHANUM CARBONATE; MAGNESIUM CARBONATE; PHOS EX; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER; UNCLASSIFIED DRUG; VITAMIN D; CALCIUM; LANTHANUM; POLYAMINE;

ACIDOSIS; APOPTOSIS; BLOOD VESSEL CALCIFICATION; CHEWING GUM; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIARRHEA; DIET RESTRICTION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG EXCRETION; DRUG METABOLISM; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOCALCEMIA; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PRIORITY JOURNAL; REVIEW; SECONDARY HYPERPARATHYROIDISM; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; BLOOD; CHILD; CHRONIC KIDNEY FAILURE; DIET; DIET THERAPY; METABOLISM; PATHOLOGY; RENAL REPLACEMENT THERAPY;

CALCIUM; CALCIUM CARBONATE; CHILD; DIET; HUMANS; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; LANTHANUM; PHOSPHATES; POLYAMINES; RENAL DIALYSIS; VASCULAR DISEASES;

EID: 77950359909     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1329-0     Document Type: Review

References (49)

1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617 (Pubitemid 28158000)
2. Prié D, Ureña Torres P, Friedlander G (2009) Latest findings in phosphate homeostasis. Kidney Int 75:882-889
3. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-592
4. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, van Manen JG, Boeschoten EW, Huisman RM, Krediet RT, Dekker FW, PREPARE study group (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22:2909-2916 (Pubitemid 350093423)
5. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520-528 (Pubitemid 41725150)
6. Goldsmith D, Ritz E, Covic A (2004) Vascular calcification: A stiff challenge for the nephrologist: Does preventing bone disease cause arterial disease? Kidney Int 66:1315-1333 (Pubitemid 39298364)
7. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR (2009) Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20:381-387
8. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM (2008) Dialysis triggers VSMC apoptosis, osteo/chodrocytic differentiation and vesicle release to cause accelerated calcification in intact human vessels. Circulation 118:1748-1757
9. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L (2008) The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 23:3263-3271
10. Bellasi A, Kooienga L, Block GA, Veledar E, Spiegel DM, Raggi P (2009) How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? J Nephrol 22:255-262
11. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesiclemediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867 (Pubitemid 41103395)
12. Shroff R, McNair R, Figg N, Skeper J, Deanfield J, Rees L, Shanahan C (2008) Arteries from Paediatric Dialysis Patients Show an Increased Susceptibility to Mineral Ion Induced Apoptosis and Oxidative Stress Leading to Accelerated Vesicle- Mediated Calcification. J Am Soc Nephrol 19:519A
13. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17
14. Giachelli CM (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75:890-897
15. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18:2996-3003 (Pubitemid 350058407)
16. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2005) Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calciumphosphorus metabolism. J Am Soc Nephrol 16:2796-2803
17. Ziolkowska H, Brzewski M, Roszkowska-Blaim M (2008) Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol 23:805-811
18. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N (2006) Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol 21:1426-1433 (Pubitemid 44283475)
19. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tröger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500 (Pubitemid 41716535)
20. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum Phosphorus Levels Associate with Coronary Atherosclerosis in Young Adults. J Am Soc Nephrol 20:397-404
21. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388-396
22. Rees L, Shaw V (2007) Nutrition in children with CRF and on dialysis. Pediatr Nephrol 22:1689-1702 (Pubitemid 47337423)
23. Salusky IB (2006) A new era in phosphate binder therapy; What are the options? Kidney Int 70:S10-S15
24. Wallot M, Bonzel KE, Winter A, Geörger B, Lettgen B, Bald M (1996) Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients. Pediatr Nephrol 10:625-630 (Pubitemid 26331777)
25. Delmez JA, Kelber J, Norword KY, Giles KS, Slatopolsky E (1996) Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study. Kidney Int 49:163-167 (Pubitemid 26024233)
26. Garland JS, Ross Morton A (2006) Sevelamer hydrochloride in peritoneal dialysis patients: Ca'canny but ca' awa. Perit Dial Int 26:300-305
27. Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB (2003) Sevelamer hydrochloride: An effective phosphate binder in dialyzed children. Pediatr Nephrol 18:1260-1264 (Pubitemid 37527101)
28. Pieper AK, Haffner D, Hoppe B, Dittrich K, Offner G, Bonzel KE, John U, Fründ S, Klaus G, Stübinger A, Düker G, Querfeld U (2006) A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis 47:625-635
29. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H (2005) Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 16:2501-2508 (Pubitemid 41725070)
30. Wesseling-Perry K, Harkins GC, Wang HJ, Sahney S, Gales B, Elashoff RM, Jüppner H, Salusky IB (2009) Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatr Nephrol 24:1355-1361
31. Hutchison AJ (2009) Oral phosphate binders. Kidney Int 75:906-914
32. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252 (Pubitemid 34754068)
33. Civilibal M, Caliskan S, Kurugoglu S, Candan C, Canpolat N, Sever L, Kasapcopur O, Arisoy N (2009) Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol 24:555-563
34. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824 (Pubitemid 43169927)
35. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438-441 (Pubitemid 46303553)
36. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK (2007) Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 72:1130-1137 (Pubitemid 47609037)
37. National Kidney Foundation (KDOQI) (2005) KDOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46(Suppl 1):S1-S122
38. Chertow GM, Dillon M, Burke SK, Steg M, Bleyer AJ, Garrett BN, Domoto DT, Wilkes BM, Wombolt DG, Slatopolsky E (1999) A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. Clin Nephrol 51:18-26
39. Savica V, Calò LA, Monardo P, Davis PA, Granata A, Santoro D, Savica R, Musolino R, Comelli MC, Bellinghieri G (2009) Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. J Am Soc Nephrol 20:639-644
40. Friedman EA (2006) Calcium-based phosphate binders are appropriate in chronic renal failure. Clin J Am Soc Nephrol 1:704-709
41. Moe SM, Chertow GM (2006) The case against calcium-based phosphate binders. Clin J Am Soc Nephrol 1:697-703
42. Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936 (Pubitemid 20362865)
43. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239-1246
44. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with endstage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483 (Pubitemid 30318271)
45. Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20:103-109
46. Matkovic V, Heaney RP (1992) Calcium balance during human growth: Evidence for threshold behaviour. Am J Clin Nutr 55:992-996
47. Abrams SA, Hicks PD, Hawthorne KM (2009) Higher serum 25-hydroxyvitamin D levels in school-age children are inconsistently associated with increased calcium absorption. J Clin Endocrinol Metab 94:2421-2427
48. KDOQI Work Group (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with Chronic Kidney Disease: 2008 update. Executive Summary. Am J Kidney Dis 53(3 Suppl 2): S11-104
49. Clayton BE, Jenkins P, Round JM (1980) Paediatric chemical pathology: Clinical tests and references ranges. Oxford: Blackwell Scientific